Nathan P. McMahon, Allison Solanki, Lei G. Wang, Antonio R. Montaño, Jocelyn A. Jones, Kimberley S. Samkoe, Kenneth M. Tichauer & Summer L. Gibbs Mol Imaging Biol. 2021 Mar 9. doi: 10.1007/s11307-021-01589-x. Online ahead of print. ABSTRACT PURPOSE: Personalized medicine has largely failed to produce curative therapies in advanced cancer patients. Evaluation of in situ drug target availability (DTA) concomitant with local…Continue Reading TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response
Day: March 22, 2021
